nodes	percent_of_prediction	percent_of_DWPC	metapath
Chlorphenamine—Neuritis—Riluzole—amyotrophic lateral sclerosis	0.0413	0.0729	CcSEcCtD
Chlorphenamine—Captodiame—SIGMAR1—amyotrophic lateral sclerosis	0.0344	0.863	CrCbGaD
Chlorphenamine—Mental disability—Riluzole—amyotrophic lateral sclerosis	0.0268	0.0472	CcSEcCtD
Chlorphenamine—Euphoric mood—Riluzole—amyotrophic lateral sclerosis	0.0265	0.0467	CcSEcCtD
Chlorphenamine—Photosensitivity—Riluzole—amyotrophic lateral sclerosis	0.0255	0.045	CcSEcCtD
Chlorphenamine—Diplopia—Riluzole—amyotrophic lateral sclerosis	0.0224	0.0395	CcSEcCtD
Chlorphenamine—SLC6A4—Synaptic Vesicle Pathway—UNC13A—amyotrophic lateral sclerosis	0.0218	0.0759	CbGpPWpGaD
Chlorphenamine—Urinary retention—Riluzole—amyotrophic lateral sclerosis	0.0213	0.0375	CcSEcCtD
Chlorphenamine—Pollakiuria—Riluzole—amyotrophic lateral sclerosis	0.0179	0.0315	CcSEcCtD
Chlorphenamine—Photosensitivity reaction—Riluzole—amyotrophic lateral sclerosis	0.0177	0.0312	CcSEcCtD
Chlorphenamine—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.0169	0.0298	CcSEcCtD
Chlorphenamine—Agranulocytosis—Riluzole—amyotrophic lateral sclerosis	0.0161	0.0284	CcSEcCtD
Chlorphenamine—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.0154	0.0272	CcSEcCtD
Chlorphenamine—Chills—Riluzole—amyotrophic lateral sclerosis	0.0139	0.0245	CcSEcCtD
Chlorphenamine—Tension—Riluzole—amyotrophic lateral sclerosis	0.0132	0.0233	CcSEcCtD
Chlorphenamine—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.0131	0.0231	CcSEcCtD
Chlorphenamine—Tremor—Riluzole—amyotrophic lateral sclerosis	0.0126	0.0223	CcSEcCtD
Chlorphenamine—Agitation—Riluzole—amyotrophic lateral sclerosis	0.0124	0.0219	CcSEcCtD
Chlorphenamine—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.0121	0.0214	CcSEcCtD
Chlorphenamine—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.0119	0.021	CcSEcCtD
Chlorphenamine—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.0117	0.0206	CcSEcCtD
Chlorphenamine—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.0116	0.0205	CcSEcCtD
Chlorphenamine—SLC6A3—nerve—amyotrophic lateral sclerosis	0.0116	0.11	CbGeAlD
Chlorphenamine—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.0114	0.0202	CcSEcCtD
Chlorphenamine—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.0112	0.0198	CcSEcCtD
Chlorphenamine—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.0111	0.0196	CcSEcCtD
Chlorphenamine—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.0108	0.019	CcSEcCtD
Chlorphenamine—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.0107	0.0189	CcSEcCtD
Chlorphenamine—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.0106	0.0188	CcSEcCtD
Chlorphenamine—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.0105	0.0185	CcSEcCtD
Chlorphenamine—SLC6A3—Parkinsons Disease Pathway—ATXN2—amyotrophic lateral sclerosis	0.0103	0.0357	CbGpPWpGaD
Chlorphenamine—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.0103	0.0181	CcSEcCtD
Chlorphenamine—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00995	0.0176	CcSEcCtD
Chlorphenamine—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00988	0.0174	CcSEcCtD
Chlorphenamine—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00978	0.0173	CcSEcCtD
Chlorphenamine—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00968	0.0171	CcSEcCtD
Chlorphenamine—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00956	0.0169	CcSEcCtD
Chlorphenamine—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00948	0.0167	CcSEcCtD
Chlorphenamine—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00941	0.0166	CcSEcCtD
Chlorphenamine—SLC6A2—nerve—amyotrophic lateral sclerosis	0.00937	0.0888	CbGeAlD
Chlorphenamine—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00906	0.016	CcSEcCtD
Chlorphenamine—SLC6A2—Na+/Cl- dependent neurotransmitter transporters—SLC6A1—amyotrophic lateral sclerosis	0.0088	0.0306	CbGpPWpGaD
Chlorphenamine—SLC6A3—hindbrain—amyotrophic lateral sclerosis	0.0087	0.0824	CbGeAlD
Chlorphenamine—SLC6A4—hindbrain—amyotrophic lateral sclerosis	0.00797	0.0755	CbGeAlD
Chlorphenamine—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00789	0.0139	CcSEcCtD
Chlorphenamine—SLC6A3—Na+/Cl- dependent neurotransmitter transporters—SLC6A1—amyotrophic lateral sclerosis	0.00779	0.0271	CbGpPWpGaD
Chlorphenamine—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00753	0.0133	CcSEcCtD
Chlorphenamine—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00727	0.0128	CcSEcCtD
Chlorphenamine—SLC22A2—Na+/Cl- dependent neurotransmitter transporters—SLC6A1—amyotrophic lateral sclerosis	0.00709	0.0246	CbGpPWpGaD
Chlorphenamine—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00699	0.0123	CcSEcCtD
Chlorphenamine—Headache—Riluzole—amyotrophic lateral sclerosis	0.00689	0.0122	CcSEcCtD
Chlorphenamine—SLC6A4—Monoamine Transport—SLC6A1—amyotrophic lateral sclerosis	0.00674	0.0234	CbGpPWpGaD
Chlorphenamine—SLC22A1—Na+/Cl- dependent neurotransmitter transporters—SLC6A1—amyotrophic lateral sclerosis	0.00661	0.023	CbGpPWpGaD
Chlorphenamine—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00653	0.0115	CcSEcCtD
Chlorphenamine—SLC6A2—Amine compound SLC transporters—SLC6A1—amyotrophic lateral sclerosis	0.0061	0.0212	CbGpPWpGaD
Chlorphenamine—SLC6A2—Monoamine Transport—SLC6A1—amyotrophic lateral sclerosis	0.0058	0.0201	CbGpPWpGaD
Chlorphenamine—SLC6A4—Circadian rythm related genes—SETX—amyotrophic lateral sclerosis	0.00553	0.0192	CbGpPWpGaD
Chlorphenamine—Clomipramine—GSTP1—amyotrophic lateral sclerosis	0.00546	0.137	CrCbGaD
Chlorphenamine—SLC6A3—Amine compound SLC transporters—SLC6A1—amyotrophic lateral sclerosis	0.00541	0.0188	CbGpPWpGaD
Chlorphenamine—SLC6A4—Synaptic Vesicle Pathway—SLC1A3—amyotrophic lateral sclerosis	0.00521	0.0181	CbGpPWpGaD
Chlorphenamine—SLC6A3—Monoamine Transport—SLC6A1—amyotrophic lateral sclerosis	0.00513	0.0178	CbGpPWpGaD
Chlorphenamine—SLC6A3—brainstem—amyotrophic lateral sclerosis	0.00499	0.0472	CbGeAlD
Chlorphenamine—SLC22A2—Amine compound SLC transporters—SLC6A1—amyotrophic lateral sclerosis	0.00492	0.0171	CbGpPWpGaD
Chlorphenamine—SLC22A1—Amine compound SLC transporters—SLC6A1—amyotrophic lateral sclerosis	0.00459	0.0159	CbGpPWpGaD
Chlorphenamine—SLC6A4—brainstem—amyotrophic lateral sclerosis	0.00457	0.0433	CbGeAlD
Chlorphenamine—CYP2D6—Melatonin metabolism and effects—ECE1—amyotrophic lateral sclerosis	0.00453	0.0157	CbGpPWpGaD
Chlorphenamine—SLC22A2—Neurotransmitter Release Cycle—CHAT—amyotrophic lateral sclerosis	0.00422	0.0147	CbGpPWpGaD
Chlorphenamine—SLC6A2—brainstem—amyotrophic lateral sclerosis	0.00402	0.0381	CbGeAlD
Chlorphenamine—SLC22A1—Neurotransmitter Release Cycle—CHAT—amyotrophic lateral sclerosis	0.00393	0.0137	CbGpPWpGaD
Chlorphenamine—CYP2D6—hindbrain—amyotrophic lateral sclerosis	0.00384	0.0364	CbGeAlD
Chlorphenamine—SLC22A2—Neurotransmitter Release Cycle—SLC6A1—amyotrophic lateral sclerosis	0.00376	0.0131	CbGpPWpGaD
Chlorphenamine—SLC22A1—Neurotransmitter Release Cycle—SLC6A1—amyotrophic lateral sclerosis	0.0035	0.0122	CbGpPWpGaD
Chlorphenamine—SLC6A4—SIDS Susceptibility Pathways—ECE1—amyotrophic lateral sclerosis	0.0033	0.0115	CbGpPWpGaD
Chlorphenamine—SLC6A3—spinal cord—amyotrophic lateral sclerosis	0.0031	0.0294	CbGeAlD
Chlorphenamine—SLC6A3—Parkinsons Disease Pathway—CASP9—amyotrophic lateral sclerosis	0.00308	0.0107	CbGpPWpGaD
Chlorphenamine—SLC6A4—spinal cord—amyotrophic lateral sclerosis	0.00284	0.0269	CbGeAlD
Chlorphenamine—SLC6A2—medulla oblongata—amyotrophic lateral sclerosis	0.0028	0.0266	CbGeAlD
Chlorphenamine—SLC6A4—NRF2 pathway—GSR—amyotrophic lateral sclerosis	0.00273	0.0095	CbGpPWpGaD
Chlorphenamine—SLC6A3—nervous system—amyotrophic lateral sclerosis	0.00261	0.0247	CbGeAlD
Chlorphenamine—SLC22A1—nervous system—amyotrophic lateral sclerosis	0.00257	0.0244	CbGeAlD
Chlorphenamine—SLC6A3—central nervous system—amyotrophic lateral sclerosis	0.00252	0.0238	CbGeAlD
Chlorphenamine—SLC22A1—central nervous system—amyotrophic lateral sclerosis	0.00248	0.0235	CbGeAlD
Chlorphenamine—SLC6A3—cerebellum—amyotrophic lateral sclerosis	0.00246	0.0233	CbGeAlD
Chlorphenamine—SLC6A4—nervous system—amyotrophic lateral sclerosis	0.00239	0.0227	CbGeAlD
Chlorphenamine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—amyotrophic lateral sclerosis	0.00239	0.00829	CbGpPWpGaD
Chlorphenamine—SLC6A2—NRF2 pathway—GSR—amyotrophic lateral sclerosis	0.00235	0.00817	CbGpPWpGaD
Chlorphenamine—SLC6A4—central nervous system—amyotrophic lateral sclerosis	0.0023	0.0218	CbGeAlD
Chlorphenamine—CYP2D6—brainstem—amyotrophic lateral sclerosis	0.0022	0.0209	CbGeAlD
Chlorphenamine—SLC6A4—SIDS Susceptibility Pathways—SLC1A3—amyotrophic lateral sclerosis	0.00213	0.0074	CbGpPWpGaD
Chlorphenamine—SLC6A4—SIDS Susceptibility Pathways—CHAT—amyotrophic lateral sclerosis	0.00213	0.0074	CbGpPWpGaD
Chlorphenamine—SLC6A4—SIDS Susceptibility Pathways—AQP4—amyotrophic lateral sclerosis	0.00213	0.0074	CbGpPWpGaD
Chlorphenamine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.00213	0.00739	CbGpPWpGaD
Chlorphenamine—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—amyotrophic lateral sclerosis	0.00211	0.00735	CbGpPWpGaD
Chlorphenamine—SLC6A2—nervous system—amyotrophic lateral sclerosis	0.00211	0.02	CbGeAlD
Chlorphenamine—SLC6A3—NRF2 pathway—GSR—amyotrophic lateral sclerosis	0.00208	0.00724	CbGpPWpGaD
Chlorphenamine—SLC6A2—central nervous system—amyotrophic lateral sclerosis	0.00203	0.0192	CbGeAlD
Chlorphenamine—SLC6A4—NRF2 pathway—SLC6A1—amyotrophic lateral sclerosis	0.002	0.00695	CbGpPWpGaD
Chlorphenamine—SLC6A3—brain—amyotrophic lateral sclerosis	0.002	0.0189	CbGeAlD
Chlorphenamine—SLC22A1—brain—amyotrophic lateral sclerosis	0.00197	0.0186	CbGeAlD
Chlorphenamine—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—amyotrophic lateral sclerosis	0.00192	0.00669	CbGpPWpGaD
Chlorphenamine—SLC6A4—brain—amyotrophic lateral sclerosis	0.00183	0.0173	CbGeAlD
Chlorphenamine—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—amyotrophic lateral sclerosis	0.00179	0.00623	CbGpPWpGaD
Chlorphenamine—SLC6A3—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.00175	0.0061	CbGpPWpGaD
Chlorphenamine—SLC6A2—NRF2 pathway—SLC6A1—amyotrophic lateral sclerosis	0.00172	0.00598	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.00164	0.00571	CbGpPWpGaD
Chlorphenamine—SLC6A3—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.00162	0.00563	CbGpPWpGaD
Chlorphenamine—SLC6A2—brain—amyotrophic lateral sclerosis	0.00161	0.0153	CbGeAlD
Chlorphenamine—SLC22A2—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.0016	0.00555	CbGpPWpGaD
Chlorphenamine—SLC6A3—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.00156	0.00543	CbGpPWpGaD
Chlorphenamine—SLC6A4—NRF2 pathway—SQSTM1—amyotrophic lateral sclerosis	0.00154	0.00536	CbGpPWpGaD
Chlorphenamine—SLC6A3—NRF2 pathway—SLC6A1—amyotrophic lateral sclerosis	0.00152	0.0053	CbGpPWpGaD
Chlorphenamine—HRH1—nervous system—amyotrophic lateral sclerosis	0.00152	0.0144	CbGeAlD
Chlorphenamine—SLC22A1—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.00149	0.00517	CbGpPWpGaD
Chlorphenamine—SLC22A2—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.00147	0.00512	CbGpPWpGaD
Chlorphenamine—SLC6A4—Circadian rythm related genes—CST3—amyotrophic lateral sclerosis	0.00147	0.0051	CbGpPWpGaD
Chlorphenamine—HRH1—central nervous system—amyotrophic lateral sclerosis	0.00146	0.0138	CbGeAlD
Chlorphenamine—SLC6A2—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.00143	0.00497	CbGpPWpGaD
Chlorphenamine—SLC6A3—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.00143	0.00497	CbGpPWpGaD
Chlorphenamine—SLC22A2—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.00142	0.00494	CbGpPWpGaD
Chlorphenamine—SLC22A1—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.00137	0.00477	CbGpPWpGaD
Chlorphenamine—SLC6A3—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00134	0.00467	CbGpPWpGaD
Chlorphenamine—SLC6A3—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.00133	0.00462	CbGpPWpGaD
Chlorphenamine—SLC6A3—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.00133	0.00462	CbGpPWpGaD
Chlorphenamine—SLC6A2—NRF2 pathway—SQSTM1—amyotrophic lateral sclerosis	0.00133	0.00461	CbGpPWpGaD
Chlorphenamine—SLC22A1—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.00133	0.00461	CbGpPWpGaD
Chlorphenamine—SLC22A2—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.0013	0.00452	CbGpPWpGaD
Chlorphenamine—SLC6A3—Parkinsons Disease Pathway—CASP3—amyotrophic lateral sclerosis	0.0013	0.00451	CbGpPWpGaD
Chlorphenamine—SLC6A3—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.00127	0.00441	CbGpPWpGaD
Chlorphenamine—SLC6A3—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00124	0.00431	CbGpPWpGaD
Chlorphenamine—SLC22A2—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00122	0.00425	CbGpPWpGaD
Chlorphenamine—SLC6A2—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.00122	0.00423	CbGpPWpGaD
Chlorphenamine—SLC22A1—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.00121	0.00422	CbGpPWpGaD
Chlorphenamine—SLC22A2—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.00121	0.0042	CbGpPWpGaD
Chlorphenamine—SLC22A2—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.00121	0.0042	CbGpPWpGaD
Chlorphenamine—SLC6A4—NRF2 pathway—GSTP1—amyotrophic lateral sclerosis	0.00121	0.00419	CbGpPWpGaD
Chlorphenamine—SLC6A3—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.0012	0.00416	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.00119	0.00412	CbGpPWpGaD
Chlorphenamine—CYP2D6—Melatonin metabolism and effects—APOE—amyotrophic lateral sclerosis	0.00119	0.00412	CbGpPWpGaD
Chlorphenamine—SLC6A3—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.00119	0.00412	CbGpPWpGaD
Chlorphenamine—SLC6A3—NRF2 pathway—SQSTM1—amyotrophic lateral sclerosis	0.00118	0.00408	CbGpPWpGaD
Chlorphenamine—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.00117	0.0111	CbGeAlD
Chlorphenamine—HRH1—brain—amyotrophic lateral sclerosis	0.00116	0.011	CbGeAlD
Chlorphenamine—CYP2D6—nervous system—amyotrophic lateral sclerosis	0.00115	0.0109	CbGeAlD
Chlorphenamine—SLC22A2—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.00115	0.00401	CbGpPWpGaD
Chlorphenamine—SLC22A1—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00114	0.00396	CbGpPWpGaD
Chlorphenamine—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.00113	0.0107	CbGeAlD
Chlorphenamine—SLC22A2—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00113	0.00392	CbGpPWpGaD
Chlorphenamine—SLC6A2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00113	0.00392	CbGpPWpGaD
Chlorphenamine—SLC22A1—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.00113	0.00392	CbGpPWpGaD
Chlorphenamine—SLC22A1—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.00113	0.00392	CbGpPWpGaD
Chlorphenamine—CYP2D6—central nervous system—amyotrophic lateral sclerosis	0.00111	0.0105	CbGeAlD
Chlorphenamine—SLC6A4—SIDS Susceptibility Pathways—BDNF—amyotrophic lateral sclerosis	0.0011	0.00383	CbGpPWpGaD
Chlorphenamine—SLC6A3—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.0011	0.00381	CbGpPWpGaD
Chlorphenamine—SLC22A2—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00109	0.00379	CbGpPWpGaD
Chlorphenamine—CYP2D6—cerebellum—amyotrophic lateral sclerosis	0.00109	0.0103	CbGeAlD
Chlorphenamine—SLC6A2—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.00108	0.00377	CbGpPWpGaD
Chlorphenamine—SLC22A2—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.00108	0.00375	CbGpPWpGaD
Chlorphenamine—SLC6A3—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.00108	0.00375	CbGpPWpGaD
Chlorphenamine—SLC22A1—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.00108	0.00374	CbGpPWpGaD
Chlorphenamine—SLC22A1—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00105	0.00366	CbGpPWpGaD
Chlorphenamine—SLC6A2—NRF2 pathway—GSTP1—amyotrophic lateral sclerosis	0.00104	0.00361	CbGpPWpGaD
Chlorphenamine—SLC6A3—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00102	0.00354	CbGpPWpGaD
Chlorphenamine—SLC6A3—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.00102	0.00354	CbGpPWpGaD
Chlorphenamine—SLC22A1—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00102	0.00353	CbGpPWpGaD
Chlorphenamine—SLC22A1—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.00101	0.00349	CbGpPWpGaD
Chlorphenamine—SLC6A3—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.001	0.00347	CbGpPWpGaD
Chlorphenamine—SLC22A2—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000997	0.00347	CbGpPWpGaD
Chlorphenamine—SLC22A2—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.000981	0.00341	CbGpPWpGaD
Chlorphenamine—SLC6A3—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.000961	0.00334	CbGpPWpGaD
Chlorphenamine—SLC22A1—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000929	0.00323	CbGpPWpGaD
Chlorphenamine—SLC22A2—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000927	0.00322	CbGpPWpGaD
Chlorphenamine—SLC22A2—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000927	0.00322	CbGpPWpGaD
Chlorphenamine—SLC6A3—NRF2 pathway—GSTP1—amyotrophic lateral sclerosis	0.000919	0.00319	CbGpPWpGaD
Chlorphenamine—SLC22A1—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.000914	0.00318	CbGpPWpGaD
Chlorphenamine—SLC22A2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00091	0.00316	CbGpPWpGaD
Chlorphenamine—SLC6A3—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000908	0.00316	CbGpPWpGaD
Chlorphenamine—CYP2D6—brain—amyotrophic lateral sclerosis	0.000882	0.00836	CbGeAlD
Chlorphenamine—SLC22A2—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.000874	0.00304	CbGpPWpGaD
Chlorphenamine—SLC22A1—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000864	0.003	CbGpPWpGaD
Chlorphenamine—SLC22A1—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000864	0.003	CbGpPWpGaD
Chlorphenamine—SLC22A1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000848	0.00295	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000844	0.00293	CbGpPWpGaD
Chlorphenamine—SLC22A2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000826	0.00287	CbGpPWpGaD
Chlorphenamine—SLC22A1—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.000815	0.00283	CbGpPWpGaD
Chlorphenamine—SLC22A1—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00077	0.00268	CbGpPWpGaD
Chlorphenamine—CYP3A7—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000735	0.00255	CbGpPWpGaD
Chlorphenamine—HRH1—Class A/1 (Rhodopsin-like receptors)—C5AR1—amyotrophic lateral sclerosis	0.000733	0.00255	CbGpPWpGaD
Chlorphenamine—SLC6A2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000727	0.00253	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000725	0.00252	CbGpPWpGaD
Chlorphenamine—SLC6A3—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000644	0.00224	CbGpPWpGaD
Chlorphenamine—SLC6A2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000618	0.00215	CbGpPWpGaD
Chlorphenamine—SLC6A2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000618	0.00215	CbGpPWpGaD
Chlorphenamine—SLC22A2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000586	0.00204	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000563	0.00196	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000563	0.00196	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000562	0.00195	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000562	0.00195	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR ligand binding—C5AR1—amyotrophic lateral sclerosis	0.000558	0.00194	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000552	0.00192	CbGpPWpGaD
Chlorphenamine—SLC6A2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000551	0.00192	CbGpPWpGaD
Chlorphenamine—SLC6A4—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	0.00055	0.00191	CbGpPWpGaD
Chlorphenamine—SLC6A3—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000548	0.0019	CbGpPWpGaD
Chlorphenamine—SLC6A3—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000548	0.0019	CbGpPWpGaD
Chlorphenamine—SLC22A1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000546	0.0019	CbGpPWpGaD
Chlorphenamine—CYP3A5—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000531	0.00185	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000524	0.00182	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000524	0.00182	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000524	0.00182	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000515	0.00179	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000514	0.00179	CbGpPWpGaD
Chlorphenamine—SLC22A2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000498	0.00173	CbGpPWpGaD
Chlorphenamine—SLC22A2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000498	0.00173	CbGpPWpGaD
Chlorphenamine—SLC6A3—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000488	0.0017	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000479	0.00167	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000479	0.00166	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000478	0.00166	CbGpPWpGaD
Chlorphenamine—SLC6A4—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	0.000467	0.00162	CbGpPWpGaD
Chlorphenamine—SLC22A1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000465	0.00161	CbGpPWpGaD
Chlorphenamine—SLC22A1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000465	0.00161	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—FIG4—amyotrophic lateral sclerosis	0.00045	0.00156	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000449	0.00156	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000446	0.00155	CbGpPWpGaD
Chlorphenamine—SLC22A2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000444	0.00154	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000419	0.00146	CbGpPWpGaD
Chlorphenamine—SLC22A1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000414	0.00144	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—DAO—amyotrophic lateral sclerosis	0.000407	0.00141	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000407	0.00141	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000407	0.00141	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—DAO—amyotrophic lateral sclerosis	0.000406	0.00141	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—DAO—amyotrophic lateral sclerosis	0.000379	0.00132	CbGpPWpGaD
Chlorphenamine—CYP2D6—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000378	0.00131	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000373	0.00129	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000372	0.00129	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000346	0.0012	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000325	0.00113	CbGpPWpGaD
Chlorphenamine—HRH1—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	0.00032	0.00111	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	0.000315	0.0011	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000309	0.00107	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000308	0.00107	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—DAO—amyotrophic lateral sclerosis	0.000294	0.00102	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000289	0.00101	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000289	0.00101	CbGpPWpGaD
Chlorphenamine—SLC6A4—Circadian rythm related genes—TP53—amyotrophic lateral sclerosis	0.000288	0.001	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000287	0.000998	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	0.000286	0.000995	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—GSR—amyotrophic lateral sclerosis	0.000285	0.000989	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—GSR—amyotrophic lateral sclerosis	0.000284	0.000988	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—GSR—amyotrophic lateral sclerosis	0.000265	0.000921	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000265	0.00092	CbGpPWpGaD
Chlorphenamine—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000247	0.000858	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000246	0.000855	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000244	0.000846	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR ligand binding—C3—amyotrophic lateral sclerosis	0.000244	0.000846	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000234	0.000812	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000233	0.000811	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000231	0.000804	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000223	0.000776	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000223	0.000775	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000218	0.000756	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.00021	0.000729	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—DAO—amyotrophic lateral sclerosis	0.000209	0.000727	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—GSR—amyotrophic lateral sclerosis	0.000206	0.000715	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000199	0.000691	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000193	0.000669	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000189	0.000658	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000189	0.000658	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000173	0.000601	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000171	0.000594	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000169	0.000588	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000169	0.000587	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000161	0.000559	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000159	0.000551	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000151	0.000526	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—GSR—amyotrophic lateral sclerosis	0.000146	0.000509	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	0.000141	0.000491	CbGpPWpGaD
Chlorphenamine—HRH1—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	0.000138	0.000478	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	0.000137	0.000475	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000126	0.000437	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000125	0.000436	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling by GPCR—C3—amyotrophic lateral sclerosis	0.000125	0.000434	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—CHAT—amyotrophic lateral sclerosis	0.00012	0.000418	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000117	0.000406	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000116	0.000404	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000115	0.000401	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000115	0.000401	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.000109	0.000379	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000107	0.000373	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.000104	0.000361	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000104	0.00036	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	9.57e-05	0.000332	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—APOE—amyotrophic lateral sclerosis	9.5e-05	0.00033	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—APOE—amyotrophic lateral sclerosis	9.49e-05	0.00033	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—GSTP1—amyotrophic lateral sclerosis	9.08e-05	0.000316	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	8.89e-05	0.000309	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—APOE—amyotrophic lateral sclerosis	8.84e-05	0.000307	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	8.35e-05	0.00029	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	8.35e-05	0.00029	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	7.86e-05	0.000273	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—C3—amyotrophic lateral sclerosis	7.38e-05	0.000257	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	6.87e-05	0.000239	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—APOE—amyotrophic lateral sclerosis	6.87e-05	0.000239	CbGpPWpGaD
Chlorphenamine—CYP3A7—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.51e-05	0.000226	CbGpPWpGaD
Chlorphenamine—SLC22A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.5e-05	0.000226	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—GSTP1—amyotrophic lateral sclerosis	6.46e-05	0.000224	CbGpPWpGaD
Chlorphenamine—SLC22A1—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.06e-05	0.000211	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.94e-05	0.000206	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	5.68e-05	0.000197	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—APOE—amyotrophic lateral sclerosis	4.88e-05	0.00017	CbGpPWpGaD
Chlorphenamine—CYP3A5—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.71e-05	0.000164	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	4.37e-05	0.000152	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.22e-05	0.000147	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	4.13e-05	0.000144	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.88e-05	0.000135	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	3.71e-05	0.000129	CbGpPWpGaD
Chlorphenamine—CYP2D6—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.35e-05	0.000116	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	3.19e-05	0.000111	CbGpPWpGaD
Chlorphenamine—HRH1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.8e-05	9.74e-05	CbGpPWpGaD
Chlorphenamine—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.19e-05	7.6e-05	CbGpPWpGaD
